Molecular Imaging Market Size, Share & Trends Analysis Report By Modality (SPECT, NMR), By Application (Oncology, Cardiology), By End-use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030
Molecular Imaging Market Growth & Trends
The global molecular imaging market size is anticipated to reach USD 11.44 billion by 2030, growing at a CAGR of 4.52% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according to the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.
The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected to significantly contribute to the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights into the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals to visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.
Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with advanced disease stages and complications.
Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohio State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming to revolutionize research in life sciences and materials science.
Molecular Imaging Market Report Highlights
- Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.8% in 2023
- The Nuclear Magnetic Resonance (NMR) Spectrometer segment is anticipated to grow at the fastest CAGR from 2024 to 2030
- Based on application, the oncology segment held the largest market share in the application segment by capturing a share of 33.7% in 2023.
- Based on end use, the hospital segment held a majority share of the market in 2023.
- Diagnostic imaging centers segment is expected to grow at the fastest rate from 2024 to 2030
- North America dominated the market with a share of 41.7% in 2023.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Modality
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Modality outlook
- 2.2.2. Application outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Molecular Imaging Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of cancer and other chronic diseases
- 3.2.1.2. Technological advancements
- 3.2.2. Market restraint analysis
- 3.2.2.1. High Cost of Equipment and Treatment
- 3.3. Molecular Imaging Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Molecular Imaging Market: Modality Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Molecular Imaging Modality Market Movement Analysis
- 4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
- 4.4. Molecular Ultrasound Imaging
- 4.4.1. Molecular ultrasound imaging market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Positron Emission Tomography (PET)
- 4.5.1. Positron emission tomography (PET) market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Single Photon Emission Computed Tomography (SPECT)
- 4.6.1. Single photon emission computed tomography (SPECT) market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
- 4.7.1. Nuclear Magnetic resonance (NMR) spectrometer market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8. Other Modalities
- 4.8.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Molecular Imaging Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Molecular Imaging Application Market Movement Analysis
- 5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Cardiovascular
- 5.4.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Neurology
- 5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Oncology
- 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Respiratory
- 5.7.1. Respiratory market estimates and forecasts 2018 to 2030 (USD Million)
- 5.8. Gastrointestinal
- 5.8.1. Gastrointestinal market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Molecular Imaging Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Molecular Imaging End Use Market Movement Analysis
- 6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Diagnostic Imaging Centers
- 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Research institutes
- 6.6.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 7. Molecular Imaging Market: Regional Estimates & Trend Analysis By Application, End Use
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Competitive scenario
- 7.5.1.3. Regulatory framework
- 7.5.1.4. Reimbursement structure
- 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. Reimbursement structure
- 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Reimbursement structure
- 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Competitive scenario
- 7.6.1.3. Regulatory framework
- 7.6.1.4. Reimbursement structure
- 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement structure
- 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. Reimbursement structure
- 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Competitive scenario
- 7.6.4.3. Regulatory framework
- 7.6.4.4. Reimbursement structure
- 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Competitive scenario
- 7.6.5.3. Regulatory framework
- 7.6.5.4. Reimbursement structure
- 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Competitive scenario
- 7.6.6.3. Regulatory framework
- 7.6.6.4. Reimbursement structure
- 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Competitive scenario
- 7.6.7.3. Regulatory framework
- 7.6.7.4. Reimbursement structure
- 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Competitive scenario
- 7.6.8.3. Regulatory framework
- 7.6.8.4. Reimbursement structure
- 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Competitive scenario
- 7.7.1.3. Regulatory framework
- 7.7.1.4. Reimbursement structure
- 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement structure
- 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement structure
- 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement structure
- 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive scenario
- 7.7.5.3. Regulatory framework
- 7.7.5.4. Reimbursement structure
- 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Competitive scenario
- 7.7.6.3. Regulatory framework
- 7.7.6.4. Reimbursement structure
- 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Competitive scenario
- 7.8.1.3. Regulatory framework
- 7.8.1.4. Reimbursement structure
- 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive scenario
- 7.8.2.3. Regulatory framework
- 7.8.2.4. Reimbursement structure
- 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Competitive scenario
- 7.9.1.3. Regulatory framework
- 7.9.1.4. Reimbursement structure
- 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Competitive scenario
- 7.9.2.3. Regulatory framework
- 7.9.2.4. Reimbursement structure
- 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Competitive scenario
- 7.9.3.3. Regulatory framework
- 7.9.3.4. Reimbursement structure
- 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Competitive scenario
- 7.9.4.3. Regulatory framework
- 7.9.4.4. Reimbursement structure
- 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Key company market share analysis, 2023
- 8.4. Company Position Analysis
- 8.5. Company Categorization (Emerging Players, Innovators and Leaders
- 8.6. Company Profiles
- 8.6.1. Bruker
- 8.6.1.1. Company overview
- 8.6.1.2. Financial performance
- 8.6.1.3. Product benchmarking
- 8.6.1.4. Strategic initiatives
- 8.6.2. GE HealthCare
- 8.6.2.1. Company overview
- 8.6.2.2. Financial performance
- 8.6.2.3. Product benchmarking
- 8.6.2.4. Strategic initiatives
- 8.6.3. Siemens Healthineers
- 8.6.3.1. Company overview
- 8.6.3.2. Financial performance
- 8.6.3.3. Product benchmarking
- 8.6.3.4. Strategic initiatives
- 8.6.4. Koninklijke Philips N.V.
- 8.6.4.1. Company overview
- 8.6.4.2. Financial performance
- 8.6.4.3. Product benchmarking
- 8.6.4.4. Strategic initiatives
- 8.6.5. Canon Medical Systems Corporation
- 8.6.5.1. Company overview
- 8.6.5.2. Financial performance
- 8.6.5.3. Product benchmarking
- 8.6.5.4. Strategic initiatives
- 8.6.6. Mediso, Cubresa Inc.
- 8.6.6.1. Company overview
- 8.6.6.2. Financial performance
- 8.6.6.3. Product benchmarking
- 8.6.6.4. Strategic initiatives
- 8.6.7. Shimadzu Corporation
- 8.6.7.1. Company overview
- 8.6.7.2. Financial performance
- 8.6.7.3. Product benchmarking
- 8.6.7.4. Strategic initiatives
- 8.6.8. United Imaging Healthcare Co
- 8.6.8.1. Company overview
- 8.6.8.2. Financial performance
- 8.6.8.3. Product benchmarking
- 8.6.8.4. Strategic initiatives
- 8.6.9. Positron Corporation
- 8.6.9.1. Company overview
- 8.6.9.2. Financial performance
- 8.6.9.3. Product benchmarking
- 8.6.9.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook